Cartesian Therapeutics, Inc.
RNAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001453687
No open-market purchases or sales by Cartesian Therapeutics, Inc. insiders were filed in the last 90 days; 94 institutions reported holding it in 13F filings for Q2 2026, worth $90.4M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Cartesian Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 102
- −4 vs. Q4 2021
- Shares held
- 57.8M
- +751.5K (+1.3%) vs. Q4 2021
- Total value
- $71.6M
- −$114.1M (−61.5%) vs. Q4 2021
- New holders
- 13
- 28 more added
- Sold out
- 17
- 41 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RNAC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 94 | $90.4M |
| Q1 2026 | 83 | $43.9M |
| Q4 2025 | 67 | $37.2M |
| Q3 2025 | 68 | $60.9M |
| Q2 2025 | 66 | $66.5M |
| Q1 2025 | 72 | $86.7M |
| Q4 2024 | 68 | $119.5M |
| Q3 2024 | 64 | $110.3M |
| Q2 2024 | 62 | $88.3M |
| Q1 2024 | 70 | $35.3M |
| Q4 2023 | 80 | $37.8M |
| Q3 2023 | 87 | $57.2M |
| Q2 2023 | 92 | $63.2M |
| Q1 2023 | 95 | $65.1M |
| Q4 2022 | 86 | $62.8M |
| Q3 2022 | 97 | $104.9M |
| Q2 2022 | 93 | $79.3M |
| Q1 2022 | 102 | $71.6M |
| Q4 2021 | 106 | $185.7M |
| Q3 2021 | 103 | $216.7M |
| Q2 2021 | 101 | $219.2M |
| Q1 2021 | 98 | $245.1M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Cartesian Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 6,764,845 | $8.32M | 0.00% | −187,037−2.7% | Reduced |
| IFP Advisors, Inc | 31,550 | – | – | +31,550 | New |
| Man Group plc | 0 | $0 | 0.00% | −179,987−100.0% | Sold out |
| ClariVest Asset Management LLC | 0 | $0 | 0.00% | −165,300−100.0% | Sold out |
| IndexIQ Advisors LLC | 0 | $0 | 0.00% | −93,327−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −88,000−100.0% | Sold out |
| Public Employees Retirement System of Ohio | 0 | $0 | 0.00% | −84,266−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −66,154−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −56,330−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −42,600−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −36,076−100.0% | Sold out |
| Healthcare of Ontario Pension Plan Trust Fund | 0 | $0 | 0.00% | −31,100−100.0% | Sold out |
| Aristides Capital LLC | 0 | $0 | 0.00% | −29,000−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −18,568−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −15,156−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −12,761−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −12,019−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −11,666−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −11,300−100.0% | Sold out |